scholarly journals Claimed Adverse Events of Korean Medicine in South Korea: Analysis of Cases in the Korea Medical Dispute Mediation and Arbitration Agency Databases

2017 ◽  
Vol 34 (3) ◽  
pp. 126-135 ◽  
Author(s):  
Hye-Won Hwang ◽  
Ji-Sun Lee ◽  
Kun Hyung Kim
Keyword(s):  
Adverse Events ◽  
South Korea ◽  
Korean Medicine ◽  
Medical Dispute ◽  
Analysis Of Cases ◽  
Dispute Mediation

scholarly journals Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies

2021 ◽  
Vol 11 (11) ◽  
pp. 4865
Author(s):  
Marta Amigo-Basilio ◽  
Covadonga Álvarez-González ◽  
Carlos Cobo-Vázquez ◽  
Isabel Leco-Berrocal ◽  
Luis Miguel Sáez-Alcaide ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Conservative Treatment ◽  
Adverse Effects ◽  
Adverse Events ◽  
Oral Cavity ◽  
Study Design ◽  
Biological Therapy ◽  
Design Analysis ◽  
Biological Therapies ◽  
Analysis Of Cases

Objective: The aim of this study is to know the biological therapy drugs that are related to adverse events, what dental treatments are associated with the appearance of these events, their severity, and how they are resolved. Study design: Analysis of cases described in the literature on patients undergoing treatment with biological therapies who have developed adverse effects associated with these drugs. Results: Of the 62 articles reviewed, 49 describe 68 cases of MRONJ, most of which appeared in the jaw and received surgical and/or conservative treatment. Conclusions: Biological therapies can potentially develop adverse effects in the oral cavity, so strict monitoring by the dentist is necessary.

scholarly journals Bypassing the Technocratic State in South Korea

2021 ◽  
Vol 16 (1) ◽  
pp. 36-57
Author(s):  
James Flowers
Keyword(s):  
Public Health ◽  
South Korea ◽  
Traditional Medicine ◽  
Herbal Medicines ◽  
The State ◽  
Financial Resources ◽  
Cultural Resources ◽  
Korean Medicine ◽  
Treatment Plans ◽  
Rapid Transmission

Abstract This article reveals an important, yet hidden, Korean response to the COVID-19 pandemic in 2020 that goes beyond the actions of the state. It focuses on the Korean medicine doctors who were excluded from any government-led public health or treatment plans for COVID-19. Bypassing the state, they used telehealth to provide herbal medicines to 20 percent of COVID-19 patients in South Korea. Traditional medicine doctors volunteered their services and financial resources to fill a gap in COVID-19 care. Most observers attribute Korean success in controlling COVID-19 to the leadership of the technocratic state with buy-in from the population. However, the case of Korea offers an example of bottom-up healthcare in a community where people chose their own native cultural resources and helps to explain how doctors were able to take the initiative to autonomously work with people in the community to help to stop the otherwise rapid transmission of the virus.

scholarly journals A Case Report of FOLFOX-induced Adverse Events in a Patient with Recurrent Advanced Gastric Cancer Treated with Korean Medicine

2020 ◽  
Vol 41 (1) ◽  
pp. 81-87
Author(s):  
Myung-hyun Ko ◽  
Jae-ho Yang ◽  
Hyung-joon Jeon ◽  
Chong-kwan Cho ◽  
Yeon-weol Lee ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Case Report ◽  
Adverse Events ◽  
Advanced Gastric Cancer ◽  
Korean Medicine

scholarly journals Hemostatic Efficacy and Safety of the Hemostatic Powder UI-EWD in Patients with Lower Gastrointestinal Bleeding

2021 ◽  
Author(s):  
Boram Cha ◽  
Dong Hyun Lee ◽  
Jongbeom Shin ◽  
Jin-Seok Park ◽  
Kye Sook Kwon ◽  
...  
Keyword(s):  
Treatment Group ◽  
Adverse Events ◽  
Gastrointestinal Bleeding ◽  
South Korea ◽  
Conventional Treatment ◽  
Therapy Group ◽  
Lower Gastrointestinal Bleeding ◽  
Endoscopic Hemostasis ◽  
Conventional Treatment Group ◽  
Hemostatic Powder

Abstract Background and Aims: Acute lower gastrointestinal bleeding (LGIB) is a common cause of emergency hospitalization and may require readmission for re-bleeding. Recently, a novel endoscopic hemostatic powder (UI-EWD/NexpowderTM, Nextbiomedical, Incheon, South Korea) was developed and applied for the control of LGIB. The aim of this study was to evaluate the hemostatic efficacy and long-term safety of UI-EWD in LGIB. Patients and Methods: We conducted a retrospective cohort study of LGIB at a single tertiary center in south korea. One hundred and sixty-seven consecutive patients with LGIB who were initially successful in endoscopic hemostasis were included and divided into the conventional treatment group (n = 112) and the UI-EWD therapy group (n = 55; 38 patients with conventional treatment and 17 patients with UI-EWD alone). The success rate of hemostasis, adverse events related to UI-EWD, and re-bleeding rate were evaluated. Results: The incidence of endoscopic hemostasis applied to the hepatic flexure (7.3% vs. 0%, p = 0.011) and larger than 4 cm (25.5% vs. 8.0%, p = 0.002) were significantly higher in the UI-EWD group than in the conventional therapy group. The cumulative rebleeding rate within 28 days in the UI-EWD group was 5.5% (3/55), which was significantly lower than that in the conventional treatment group (17.0% [19/112]; p = 0.039). No UI-EWD-related adverse events were recorded.Conclusion: Based on our results, application of UI-EWD in LGIB showed promising results for the prevention of re-bleeding, especially in locations where it is difficult to approach or cases with more bleeding. There were no significant complications, such as perforation or embolism. In particular, UI-EWD should be considered first for anatomical or technical impediments to endoscopic access in LGIB.

scholarly journals Telemedicine and the use of Korean Medicine with COVID-19 patients in South Korea: an observational study (Preprint)

10.2196/20236 ◽  
2020 ◽  
Author(s):  
Soobin Jang ◽  
Dongsu Kim ◽  
Eunhee Yi ◽  
Gunhee Choi ◽  
Mideok Song ◽  
...  
Keyword(s):  
Observational Study ◽  
South Korea ◽  
Korean Medicine
Sign in / Sign up

Export Citation Format

Share Document